Thromboxane A2/ prostaglandin H2 receptors in streptozotocin-induced diabetes: Effects of insulin therapy in the rat

Halushka, 1989, Thromboxane, prostaglandin and leukotriene receptors, Annu. Rev. Pharm. Tox., 29, 213, 10.1146/annurev.pa.29.040189.001241 Mayfield, 1985, Platelet function during continuous insulin infusion treatment in insulin-dependent diabetic patients, Diabetes, 34, 1127, 10.2337/diabetes.34.11.1127 Davi, 1990, Thromboxane biosynthesis and platelet function in type II diabetes mellitus, New Eng. J. Med., 322, 1769, 10.1056/NEJM199006213222503 Boura, 1986, Changes in cardiovascular sensitivity of alloxan-treated diabetic rats to arachidonic acid, Br. J. Pharmac, 89, 613, 10.1111/j.1476-5381.1986.tb11163.x Somova, 1988, Pathogenesis of cardiovascular disorders in streptozotcin-induced diabetes in rat. II. Correlation between lipid peroxides, Thromboxane A2/ prostacyclin, and platelet aggregation in different stages of diabetes, Acta. Physiol. Pharmacol. Bulg., 14, 57 Koltai, 1988, Relationship between vascular adrenergic receptors and prostaglandin biosynthesis in canine diabetic coronary arteries, Diabetologia, 31, 681, 10.1007/BF00278752 Kubisz, 1984, Investigations on platelet function in diabetes mellitus, Haemostasis, 14, 347 Sterin-Borda, 1981, Prostacyclin (PGI2) and U-46619 stimulate coronary arteries from diabetic dogs and their action is influenced by inhibitors of prostaglandin biosynthesis, Prostaglandins, 22, 267, 10.1016/0090-6980(81)90041-1 Roth, 1983, Vascular responsiveness and eicosanoid production in diabetic rats, Diabetologia, 24, 372, 10.1007/BF00251827 Takiguchi, 1989, Involvement of thromboxane and leukotriene in arachidonate induced coronary constriction in diabetic rats, Diabetologia, 32, 337, 10.1007/BF00277255 Tesfamariam, 1989, Contraction of diabetic rabbit aorta caused by endothelium-derived PGH2-TXA2, Am. J. Physiol., 257, H1327 Kimura, 1989, Diabetes-induced enhancement of prostanoid-stimulated contraction in mesenteric veins of mice, Japan J. Pharmacol., 51, 403, 10.1254/jjp.51.403 Sarubbi, 1989, Renal vascular responses and eicosanoid release in diabetic rats, Am. J. Physiol., 256, F762 Quilley, 1990, Renal vascular responsiveness to arachidonic acid in experimental diabetes, Br. J. Pharmacol., 100, 336, 10.1111/j.1476-5381.1990.tb15805.x Folger, 1991, Response of rat thoracic aortic rings to thromboxane mimetic U46619: Roles of endothelium-derived relaxing factor and thromboxane A2 release, Jour. Pharm. Exper. Therap., 258, 669 Edwards, 1989, Influences of exogenous insulin on arterial blood pressure measurements of the rat, J. Appl. Physiol., 67, 2335, 10.1152/jappl.1989.67.6.2335 Yanagisawa-Miwa, 1990, Effects of insulin on vasoconstriction induced by thromboxane A2 in porcine coronary artery, Circulation, 81, 1654, 10.1161/01.CIR.81.5.1654 Morinelli, 1989, Characterization of an 125I-labeled thromboxane A2/prostaglandin H2 receptor agonist, J. Pharmacol. and Exper. Therap., 251, 557 Jaffa, 1987, Abnormal regulation of renal kallikrein in experimental diabetes. Effects of insulin on prokallikrein synthesis and activation, J. Clin. Inves., 80, 1651, 10.1172/JCI113254 Harvey, 1990, Renal kallikrein and hemodynamic abnormalities of diabetic kidney, Diabetes, 39, 299, 10.2337/diabetes.39.3.299 Sessa, 1990, Characterization of the vascular thromboxane A2/prostaglandin endoperoxide receptor in rabbit aorta: Regulation by dexamethasone, Circ. Res., 67, 1562, 10.1161/01.RES.67.6.1562 Folger, 1992, Characterization of rat glomerular thromboxane A2 receptors: comparison to rat platelets, Euro. Jour. of Pharmac., 227, 71, 10.1016/0922-4106(92)90144-K Gillard, 1989, The use of synthetic thromboxane A2 (TXA2S) and a new class of thromboxane antagonists, indole-2-propanoic acids to characterize the thromboxane receptor, Prostaglandins in Clin. Res., 579 Munson, 1980, LIGAND: A versitile computerized approach for characterization of ligand-binding systems, Anal. Biochem., 107, 220, 10.1016/0003-2697(80)90515-1 Jaschonek, 1989, Platelet thromboxane A2/endoperoxide (TXA2/PGH2) receptors in type 1 diabetes mellitus, Thrombosis and Haemostasis, 61, 535, 10.1055/s-0038-1646631 Agrawal, 1987, Vascular responses to agonists in rat mesenteric artery from diabetic rats, Can. J. Physiol. Pharmacol., 65, 1484, 10.1139/y87-232 Kamata, 1988, Mechanisms of increased responses of the aorta to alpha-adrenoceptor agonists in streptozotocin-induced diabetic rats, J. Pharmacobiodyn., 11, 707, 10.1248/bpb1978.11.707 White, 1988, Enhanced vascular α-adrenergic neureffector system in diabetes: importance of calcium, Am. J. Physiol., 255, H1036 White, 1990, Vascular contraction induced by activation of membrane calcium ion channels is enhanced in streptozotocin-diabetes, J. of Pharmacol. and Exper. Therap., 253, 1057 Arnqvist, 1978, Time course of the effect of insulin on bovine mesenteric artery, Pharmacol. Toxicol., 42, 169 Ishimitsu, 1988, Thromboxane and vascular smooth muscle growth in genetically hypertensive rats, Hypertension, 12, 46, 10.1161/01.HYP.12.1.46 Hanasaki, 1990, Receptor-mediated mitogenic effect of thromboxane A2 in vascular smooth muscle cells, Biochem. Pharmacol., 40, 2535, 10.1016/0006-2952(90)90096-4 Ledbetter, 1990, Altered steady-state mRNA levels of basement membrane proteins in diabetic mouse kidneys and thromboxane synthase inhibition, Diabetes, 39, 196, 10.2337/diabetes.39.2.196 Bruggeman, 1991, Thromboxane stimulates synthesis of extracellular matrix proteins in vitro, Am. J. Physiol., 261, F488